Skip to main content
Top
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | SARS-CoV-2 | Research

Post-recovery health domain scores among outpatients by SARS-CoV-2 testing status during the pre-Delta period

Authors: Jennifer P. King, Jessie R. Chung, James G. Donahue, Emily T. Martin, Aleda M. Leis, Arnold S. Monto, Manjusha Gaglani, Kayan Dunnigan, Chandni Raiyani, Sharon Saydah, Brendan Flannery, Edward A. Belongia

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

Background

Symptoms of COVID-19 including fatigue and dyspnea, may persist for weeks to months after SARS-CoV-2 infection. This study compared self-reported disability among SARS-CoV-2-positive and negative persons with mild to moderate COVID-19-like illness who presented for outpatient care before widespread COVID-19 vaccination.

Methods

Unvaccinated adults with COVID-19-like illness enrolled within 10 days of illness onset at three US Flu Vaccine Effectiveness Network sites were tested for SARS-CoV-2 by molecular assay. Enrollees completed an enrollment questionnaire and two follow-up surveys (7–24 days and 2–7 months after illness onset) online or by phone to assess illness characteristics and health status. The second follow-up survey included questions measuring global health, physical function, fatigue, and dyspnea. Scores in the four domains were compared by participants’ SARS-CoV-2 test results in univariate analysis and multivariable Gamma regression.

Results

During September 22, 2020 – February 13, 2021, 2712 eligible adults were enrolled, 1541 completed the first follow-up survey, and 650 completed the second follow-up survey. SARS-CoV-2-positive participants were more likely to report fever at acute illness but were otherwise comparable to SARS-CoV-2-negative participants. At first follow-up, SARS-CoV-2-positive participants were less likely to have reported fully or mostly recovered from their illness compared to SARS-CoV-2-negative participants. At second follow-up, no differences by SARS-CoV-2 test results were detected in the four domains in the multivariable model.

Conclusion

Self-reported disability was similar among outpatient SARS-CoV-2-positive and -negative adults 2–7 months after illness onset.
Appendix
Available only for authorised users
Literature
1.
go back to reference Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–20.CrossRefPubMed Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–20.CrossRefPubMed
2.
go back to reference Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in critically ill patients in the Seattle region - case series. N Engl J Med. 2020;382(21):2012–22.CrossRefPubMed Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in critically ill patients in the Seattle region - case series. N Engl J Med. 2020;382(21):2012–22.CrossRefPubMed
4.
5.
go back to reference O'Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. eClinicalMedicine. 2023;55:101762.CrossRefPubMed O'Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. eClinicalMedicine. 2023;55:101762.CrossRefPubMed
6.
go back to reference Hastie CE, Lowe DJ, McAuley A, Winter AJ, Mills NL, Black C, et al. Outcomes among confirmed cases and a matched comparison group in the long-COVID in Scotland study. Nat Commun. 2022;13(1):5663.ADSCrossRefPubMedPubMedCentral Hastie CE, Lowe DJ, McAuley A, Winter AJ, Mills NL, Black C, et al. Outcomes among confirmed cases and a matched comparison group in the long-COVID in Scotland study. Nat Commun. 2022;13(1):5663.ADSCrossRefPubMedPubMedCentral
8.
go back to reference Robertson MM, Qasmieh SA, Kulkarni SG, Teasdale CA, Jones HE, McNairy M, et al. The epidemiology of long coronavirus disease in US adults. Clin Infect Dis. 2023;76(9):1636–45.CrossRefPubMed Robertson MM, Qasmieh SA, Kulkarni SG, Teasdale CA, Jones HE, McNairy M, et al. The epidemiology of long coronavirus disease in US adults. Clin Infect Dis. 2023;76(9):1636–45.CrossRefPubMed
9.
go back to reference Sørensen AIV, Spiliopoulos L, Bager P, Nielsen NM, Hansen JV, Koch A, et al. A nationwide questionnaire study of post-acute symptoms and health problems after SARS-CoV-2 infection in Denmark. Nat Commun. 2022;13(1):4213.ADSCrossRefPubMedPubMedCentral Sørensen AIV, Spiliopoulos L, Bager P, Nielsen NM, Hansen JV, Koch A, et al. A nationwide questionnaire study of post-acute symptoms and health problems after SARS-CoV-2 infection in Denmark. Nat Commun. 2022;13(1):4213.ADSCrossRefPubMedPubMedCentral
10.
go back to reference Atchison CJ, Davies B, Cooper E, Lound A, Whitaker M, Hampshire A, et al. Long-term health impacts of COVID-19 among 242,712 adults in England. Nat Commun. 2023;14(1):6588.ADSCrossRefPubMedPubMedCentral Atchison CJ, Davies B, Cooper E, Lound A, Whitaker M, Hampshire A, et al. Long-term health impacts of COVID-19 among 242,712 adults in England. Nat Commun. 2023;14(1):6588.ADSCrossRefPubMedPubMedCentral
11.
go back to reference Zhang P, Li J, Liu H, Han N, Ju J, Kou Y, et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Res. 2020;8:8.CrossRefPubMedPubMedCentral Zhang P, Li J, Liu H, Han N, Ju J, Kou Y, et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Res. 2020;8:8.CrossRefPubMedPubMedCentral
12.
go back to reference Bull-Otterson L, Baca S, Saydah S, Boehmer TK, Adjei S, Gray S, et al. Post–COVID conditions among adult COVID-19 survivors aged 18–64 and ≥65 years — United States, march 2020–November 2021. Morb Mortal Wkly. 2022;71(21):713–7.CrossRef Bull-Otterson L, Baca S, Saydah S, Boehmer TK, Adjei S, Gray S, et al. Post–COVID conditions among adult COVID-19 survivors aged 18–64 and ≥65 years — United States, march 2020–November 2021. Morb Mortal Wkly. 2022;71(21):713–7.CrossRef
13.
go back to reference Tenforde MW, Devine OJ, Reese HE, Silk BJ, Iuliano AD, Threlkel R, et al. Point prevalence estimates of activity-limiting long-term symptoms among United States adults ≥1 month after reported severe acute respiratory syndrome coronavirus 2 infection, 1 November 2021. J Infect Dis. 2022;227(7):855–63.CrossRef Tenforde MW, Devine OJ, Reese HE, Silk BJ, Iuliano AD, Threlkel R, et al. Point prevalence estimates of activity-limiting long-term symptoms among United States adults ≥1 month after reported severe acute respiratory syndrome coronavirus 2 infection, 1 November 2021. J Infect Dis. 2022;227(7):855–63.CrossRef
17.
go back to reference Chung JR, Kim SS, Jackson ML, Jackson LA, Belongia EA, King JP, et al. Clinical symptoms among ambulatory patients tested for SARS-CoV-2. Open forum. Infect Dis. 2021;8(1):ofaa576. Chung JR, Kim SS, Jackson ML, Jackson LA, Belongia EA, King JP, et al. Clinical symptoms among ambulatory patients tested for SARS-CoV-2. Open forum. Infect Dis. 2021;8(1):ofaa576.
18.
go back to reference Shafer L, Ahmed F, Kim S, Wernli KJ, Jackson ML, Nowalk MP, et al. Relationship between telework experience and Presenteeism during COVID-19 pandemic, United States, march-November 2020. Emerg Infect Dis. 2023;29(2):278–85.CrossRefPubMedPubMedCentral Shafer L, Ahmed F, Kim S, Wernli KJ, Jackson ML, Nowalk MP, et al. Relationship between telework experience and Presenteeism during COVID-19 pandemic, United States, march-November 2020. Emerg Infect Dis. 2023;29(2):278–85.CrossRefPubMedPubMedCentral
20.
go back to reference Bingham Iii CO, Gutierrez AK, Butanis A, Bykerk VP, Curtis JR, Leong A, et al. PROMIS fatigue short forms are reliable and valid in adults with rheumatoid arthritis. J Patient Rep Outcomes. 2019;3(1):14.CrossRefPubMedPubMedCentral Bingham Iii CO, Gutierrez AK, Butanis A, Bykerk VP, Curtis JR, Leong A, et al. PROMIS fatigue short forms are reliable and valid in adults with rheumatoid arthritis. J Patient Rep Outcomes. 2019;3(1):14.CrossRefPubMedPubMedCentral
21.
go back to reference Jensen RE, Potosky AL, Reeve BB, Hahn E, Cella D, Fries J, et al. Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients. Qual Life Res. 2015;24(10):2333–44.CrossRefPubMedPubMedCentral Jensen RE, Potosky AL, Reeve BB, Hahn E, Cella D, Fries J, et al. Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients. Qual Life Res. 2015;24(10):2333–44.CrossRefPubMedPubMedCentral
22.
go back to reference Cook KF, Jensen SE, Schalet BD, Beaumont JL, Amtmann D, Czajkowski S, et al. PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions. J Clin Epidemiol. 2016;73:89–102.CrossRefPubMedPubMedCentral Cook KF, Jensen SE, Schalet BD, Beaumont JL, Amtmann D, Czajkowski S, et al. PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions. J Clin Epidemiol. 2016;73:89–102.CrossRefPubMedPubMedCentral
23.
go back to reference Schalet BD, Hays RD, Jensen SE, Beaumont JL, Fries JF, Cella D. Validity of PROMIS physical function measured in diverse clinical samples. J Clin Epidemiol. 2016;73:112–8.CrossRefPubMedPubMedCentral Schalet BD, Hays RD, Jensen SE, Beaumont JL, Fries JF, Cella D. Validity of PROMIS physical function measured in diverse clinical samples. J Clin Epidemiol. 2016;73:112–8.CrossRefPubMedPubMedCentral
24.
go back to reference Cella D, Lai JS, Jensen SE, Christodoulou C, Junghaenel DU, Reeve BB, et al. PROMIS fatigue item Bank had clinical validity across diverse chronic conditions. J Clin Epidemiol. 2016;73:128–34.CrossRefPubMedPubMedCentral Cella D, Lai JS, Jensen SE, Christodoulou C, Junghaenel DU, Reeve BB, et al. PROMIS fatigue item Bank had clinical validity across diverse chronic conditions. J Clin Epidemiol. 2016;73:128–34.CrossRefPubMedPubMedCentral
25.
go back to reference Rose M, Bjorner JB, Gandek B, Bruce B, Fries JF, Ware JE Jr. The PROMIS physical function item bank was calibrated to a standardized metric and shown to improve measurement efficiency. J Clin Epidemiol. 2014;67(5):516–26.CrossRefPubMedPubMedCentral Rose M, Bjorner JB, Gandek B, Bruce B, Fries JF, Ware JE Jr. The PROMIS physical function item bank was calibrated to a standardized metric and shown to improve measurement efficiency. J Clin Epidemiol. 2014;67(5):516–26.CrossRefPubMedPubMedCentral
26.
go back to reference Cella D, Choi SW, Condon DM, Schalet B, Hays RD, Rothrock NE, et al. PROMIS(®) adult health profiles: efficient short-form measures of seven health domains. Value Health. 2019;22(5):537–44.CrossRefPubMedPubMedCentral Cella D, Choi SW, Condon DM, Schalet B, Hays RD, Rothrock NE, et al. PROMIS(®) adult health profiles: efficient short-form measures of seven health domains. Value Health. 2019;22(5):537–44.CrossRefPubMedPubMedCentral
27.
go back to reference Garson GD. Generalized linear models / generalized estimating equations. 2013. Asheboro, NC: Statistical Associates Publishers; 2013. Garson GD. Generalized linear models / generalized estimating equations. 2013. Asheboro, NC: Statistical Associates Publishers; 2013.
28.
go back to reference Gottlieb M, Wang RC, Yu H, Spatz ES, Montoy JCC, Rodriguez RM, et al. Severe fatigue and persistent symptoms at 3 months following severe acute respiratory syndrome coronavirus 2 infections during the Pre-Delta, Delta, and omicron time periods: a multicenter prospective cohort study. Clin Infect Dis. 2023;76(11):1930–41.CrossRefPubMedPubMedCentral Gottlieb M, Wang RC, Yu H, Spatz ES, Montoy JCC, Rodriguez RM, et al. Severe fatigue and persistent symptoms at 3 months following severe acute respiratory syndrome coronavirus 2 infections during the Pre-Delta, Delta, and omicron time periods: a multicenter prospective cohort study. Clin Infect Dis. 2023;76(11):1930–41.CrossRefPubMedPubMedCentral
29.
go back to reference Català M, Mercadé-Besora N, Kolde R, Trinh NTH, Roel E, Burn E, et al. The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir Med. 2024; Català M, Mercadé-Besora N, Kolde R, Trinh NTH, Roel E, Burn E, et al. The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia. Lancet Respir Med. 2024;
30.
go back to reference Havervall S, Rosell A, Phillipson M, Mangsbo SM, Nilsson P, Hober S, et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. Jama. 2021;325(19):2015–6.CrossRefPubMedPubMedCentral Havervall S, Rosell A, Phillipson M, Mangsbo SM, Nilsson P, Hober S, et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. Jama. 2021;325(19):2015–6.CrossRefPubMedPubMedCentral
31.
go back to reference Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, march-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993–8.CrossRefPubMedPubMedCentral Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, march-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993–8.CrossRefPubMedPubMedCentral
32.
go back to reference Ganesh R, Ghosh AK, Nyman MA, Croghan IT, Grach SL, Anstine CV, et al. PROMIS scales for assessment of persistent post-COVID symptoms: a cross sectional study. J Prim Care Community Health. 2021;12:21501327211030413.CrossRefPubMedPubMedCentral Ganesh R, Ghosh AK, Nyman MA, Croghan IT, Grach SL, Anstine CV, et al. PROMIS scales for assessment of persistent post-COVID symptoms: a cross sectional study. J Prim Care Community Health. 2021;12:21501327211030413.CrossRefPubMedPubMedCentral
33.
go back to reference Hernandez-Romieu AC, Carton TW, Saydah S, Azziz-Baumgartner E, Boehmer TK, Garret NY, et al. Prevalence of select new symptoms and conditions among persons aged younger than 20 years and 20 years or older at 31 to 150 days after testing positive or negative for SARS-CoV-2. JAMA Netw Open. 2022;5(2):e2147053.CrossRefPubMedPubMedCentral Hernandez-Romieu AC, Carton TW, Saydah S, Azziz-Baumgartner E, Boehmer TK, Garret NY, et al. Prevalence of select new symptoms and conditions among persons aged younger than 20 years and 20 years or older at 31 to 150 days after testing positive or negative for SARS-CoV-2. JAMA Netw Open. 2022;5(2):e2147053.CrossRefPubMedPubMedCentral
34.
go back to reference Selvakumar J, Havdal LB, Drevvatne M, Brodwall EM, Lund Berven L, Stiansen-Sonerud T, et al. Prevalence and characteristics associated with post-COVID-19 condition among nonhospitalized adolescents and young adults. JAMA Netw Open. 2023;6(3):e235763.CrossRefPubMedPubMedCentral Selvakumar J, Havdal LB, Drevvatne M, Brodwall EM, Lund Berven L, Stiansen-Sonerud T, et al. Prevalence and characteristics associated with post-COVID-19 condition among nonhospitalized adolescents and young adults. JAMA Netw Open. 2023;6(3):e235763.CrossRefPubMedPubMedCentral
35.
go back to reference Wisk LE, Gottlieb MA, Spatz ES, Yu H, Wang RC, Slovis BH, et al. Association of Initial SARS-CoV-2 test positivity with patient-reported well-being 3 months after a symptomatic illness. JAMA Netw Open. 2022;5(12):e2244486.CrossRefPubMedPubMedCentral Wisk LE, Gottlieb MA, Spatz ES, Yu H, Wang RC, Slovis BH, et al. Association of Initial SARS-CoV-2 test positivity with patient-reported well-being 3 months after a symptomatic illness. JAMA Netw Open. 2022;5(12):e2244486.CrossRefPubMedPubMedCentral
36.
go back to reference Fisher KA, Olson SM, Tenforde MW, Self WH, Wu M, Lindsell CJ, et al. Symptoms and recovery among adult outpatients with and without COVID-19 at 11 healthcare facilities-July 2020, United States. Influenza Other Respir Viruses. 2021;15(3):345–51.CrossRefPubMedPubMedCentral Fisher KA, Olson SM, Tenforde MW, Self WH, Wu M, Lindsell CJ, et al. Symptoms and recovery among adult outpatients with and without COVID-19 at 11 healthcare facilities-July 2020, United States. Influenza Other Respir Viruses. 2021;15(3):345–51.CrossRefPubMedPubMedCentral
37.
go back to reference Ahmed F, Kim S, Nowalk MP, King JP, VanWormer JJ, Gaglani M, et al. Paid leave and access to telework as work attendance determinants during acute respiratory illness, United States, 2017-2018. Emerg Infect Dis. 2020;26(1):26–33.CrossRefPubMedPubMedCentral Ahmed F, Kim S, Nowalk MP, King JP, VanWormer JJ, Gaglani M, et al. Paid leave and access to telework as work attendance determinants during acute respiratory illness, United States, 2017-2018. Emerg Infect Dis. 2020;26(1):26–33.CrossRefPubMedPubMedCentral
38.
go back to reference Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun. 2022;101:93–135.CrossRefPubMed Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun. 2022;101:93–135.CrossRefPubMed
39.
go back to reference Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022;28(5):911–23.CrossRefPubMed Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022;28(5):911–23.CrossRefPubMed
40.
go back to reference Huang L, Li X, Gu X, Zhang H, Ren L, Guo L, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022;10(9):863–76.CrossRefPubMedPubMedCentral Huang L, Li X, Gu X, Zhang H, Ren L, Guo L, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022;10(9):863–76.CrossRefPubMedPubMedCentral
41.
go back to reference Shang MC, Chung JR, Jackson ML, Jackson LA, Monto AS, Martin ET, et al. Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016. Vaccine. 2018;36(52):8047–53.CrossRefPubMedPubMedCentral Shang MC, Chung JR, Jackson ML, Jackson LA, Monto AS, Martin ET, et al. Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016. Vaccine. 2018;36(52):8047–53.CrossRefPubMedPubMedCentral
42.
go back to reference Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. EClinicalMedicine. 2022;53:101624.CrossRefPubMedPubMedCentral Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. EClinicalMedicine. 2022;53:101624.CrossRefPubMedPubMedCentral
Metadata
Title
Post-recovery health domain scores among outpatients by SARS-CoV-2 testing status during the pre-Delta period
Authors
Jennifer P. King
Jessie R. Chung
James G. Donahue
Emily T. Martin
Aleda M. Leis
Arnold S. Monto
Manjusha Gaglani
Kayan Dunnigan
Chandni Raiyani
Sharon Saydah
Brendan Flannery
Edward A. Belongia
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2024
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09108-3

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine